Acknowledgement to Reviewers

Código QR

Acknowledgement to Reviewers

Guardado en:

Detalles Bibliográficos
Formato:	article
Lenguaje:	EN
Publicado:	Karger Publishers 2021
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/05bd1f96b9104e0e91c962cc8ac84447
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Nutritional therapy for the management of diabetic gastroparesis: clinical review
por: Sadiya A
Publicado: (2012)

Prevalence of overweight and obesity in adult Nigerians &ndash; a systematic review
por: Chukwuonye II, et al.
Publicado: (2013)

Systematic review of clinical studies related to pork intake and metabolic syndrome or its components
por: Stettler N, et al.
Publicado: (2013)

The effect of very low-calorie diets on renal and hepatic outcomes: a systematic review
por: Roll, et al.
Publicado: (2013)

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review
por: Gregory E Peterson
Publicado: (2009)

Egg consumption and cardiovascular disease among diabetic individuals: a systematic review of the literature
por: Tran NL, et al.
Publicado: (2014)

Is adherence a relevant issue in the self-management education of diabetes? A mixed narrative review
por: Debussche X
Publicado: (2014)

Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: a systematic review
por: Holmes C, et al.
Publicado: (2013)

Insulin degludec as an ultralong-acting basal insulin once a day: a systematic review
por: Wang F, et al.
Publicado: (2012)

Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management
por: Nitzan O, et al.
Publicado: (2015)

Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes &ndash; a review
por: Katrine B Hansen, et al.
Publicado: (2010)

Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review
por: Colosia AD, et al.
Publicado: (2013)

The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents
por: Sonia A Tucci, et al.
Publicado: (2010)

Glucagon-like peptide-1 receptor agonists as add-on therapy to basal insulin in patients with type 2 diabetes: a systematic review
por: Berlie H, et al.
Publicado: (2012)

Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey
por: Sadosky A, et al.
Publicado: (2013)

Metformin and Malignant Tumors: Not Over the Hill [Response to Letter]
por: Leng W, et al.
Publicado: (2021)

Rag2 Deficiency Enhances Susceptibility to Systemic Mouse Adenovirus Type 1 Infection
por: Han-Kyul Lee, et al.
Publicado: (2021)

The Features of Pathobiology and Clinical translation of Approved treatments for Coronavirus Disease 2019 (COVID-19)
por: Ali Fallah, et al.
Publicado: (2021)

Molecular detection of parvovirus in Manchurian chipmunks (Tamias sibiricus asiaticus) captured in Korea
por: Jin Il Kim, et al.
Publicado: (2021)

Hepatitis E virus capsid as a carrier of exogenous antigens for the development of chimeric virus-like particles
por: Tianyu Lu, et al.
Publicado: (2021)

Are previous viral infections important on the COVID-19 outcomes?
por: Jesus Torres-Flores, et al.
Publicado: (2021)

Correspondence on “prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection”
por: Rujittika Mungmunpuntipantip, et al.
Publicado: (2021)

The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population
por: Qunying Yang, et al.
Publicado: (2021)

Editorial Board
Publicado: (2021)

Reply to: The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population
por: Hirsh D. Trivedi, et al.
Publicado: (2021)

Case completeness in the Norwegian Cardiac Arrest Registry
por: Kristin Alm-Kruse, et al.
Publicado: (2021)

Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study
por: Penfornis A, et al.
Publicado: (2015)

Arab Teens Lifestyle Study (ATLS): objectives, design, methodology and implications
por: Musaiger AO; ATLS Research Group, et al.
Publicado: (2011)

Effect of a low-carbohydrate diet versus a low-fat, calorie-restricted diet on adipokine levels in obese, diabetic participants
por: Marion L Vetter, et al.
Publicado: (2010)

Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia
por: Anderson M, et al.
Publicado: (2014)

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
por: Zambad SP, et al.
Publicado: (2013)

Relationship between oxidized low-density lipoprotein antibodies and obesity in different glycemic situations
por: Babakr AT, et al.
Publicado: (2014)

Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice
por: Fuchs D, et al.
Publicado: (2012)

Anorexia nervosa depends on adrenal sympathetic hyperactivity: opposite neuroautonomic profile of hyperinsulinism syndrome
por: Fuad Lechin, et al.
Publicado: (2010)

Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
por: Peter J Donovan, et al.
Publicado: (2010)

Hepatic function and the cardiometabolic syndrome
por: Wiernsperger N
Publicado: (2013)

Effects of body mass index-related disorders on cognition: preliminary results
por: Yesavage JA, et al.
Publicado: (2014)

Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism
por: Mauro AM Carai, et al.
Publicado: (2009)

Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins
por: Di Pierro F, et al.
Publicado: (2015)

SGLT2 inhibitors – an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin
por: Seufert J
Publicado: (2015)